Mannkind (MNKD) Cash from Financing Activities (2010 - 2026)

Mannkind (MNKD) reported Cash from Financing Activities of -$35.4 million for Q1 2026, down 2647.19% year-over-year from $1.4 million in Q1 2025, and down 114.31% quarter-over-quarter from $247.4 million in Q4 2025.

Mannkind (MNKD) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Mannkind (MNKD) has 17 years of Cash from Financing Activities data on file, last reported at -$35.4 million in Q1 2026.

  • Cash from Financing Activities for Q1 2026 came in at -$35.4 million, down 2647.19% year-over-year; the trailing twelve-month figure through Mar 2026 was $278.3 million (up 310.2% YoY), and the FY2025 annual result was $315.1 million, up 329.55% from the prior year.
  • Cash from Financing Activities fell to -$35.4 million in Q1 2026 per MNKD's latest filing, from $247.4 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $247.4 million in Q4 2025 and troughed at -$86.9 million in Q4 2024.
  • A 5-year average of $17.7 million and a median of -$283000.0 in 2023 frame the typical range for Cash from Financing Activities.
  • The sharpest annual moves came in 2023 and 2026: Cash from Financing Activities jumped 4915.26% in 2023, then plunged 2647.19% in 2026.
  • A 5-year view of Cash from Financing Activities shows it stood at $2.8 million in 2022, then jumped by 4915.26% to $141.7 million in 2023, then plunged by 161.33% to -$86.9 million in 2024, then soared by 384.71% to $247.4 million in 2025, then plunged by 114.31% to -$35.4 million in 2026.
  • Business Quant data shows MNKD's Cash from Financing Activities at -$35.4 million in Q1 2026, $247.4 million in Q4 2025, and $71.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 7.00 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -600,000.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 53,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -538.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - 85,464.43
10 Mannkind 1.21 Bn 1.08 Bn 82.66 Mn -35.41 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -35.41 Mn
Mar 31, 2026 -35.41 Mn
Dec 31, 2025 247.41 Mn
Dec 31, 2025 247.41 Mn
Sep 30, 2025 71.81 Mn
Sep 30, 2025 71.81 Mn
Jun 30, 2025 -5.51 Mn
Jun 30, 2025 -5.51 Mn
Mar 31, 2025 1.39 Mn
Mar 31, 2025 1.39 Mn
Dec 31, 2024 -86.90 Mn
Dec 31, 2024 -86.90 Mn
Sep 30, 2024 -2.34 Mn
Sep 30, 2024 -2.34 Mn
Jun 30, 2024 -44.55 Mn
Jun 30, 2024 -44.55 Mn
Mar 31, 2024 -3.47 Mn
Mar 31, 2024 -3.47 Mn
Dec 31, 2023 141.68 Mn
Dec 31, 2023 141.68 Mn